1,635 reports of this reaction
16.5% of all TASIMELTEON reports
#1 most reported adverse reaction
DRUG INEFFECTIVE is the #1 most commonly reported adverse reaction for TASIMELTEON, manufactured by Vanda Pharmaceuticals Inc.. There are 1,635 FDA adverse event reports linking TASIMELTEON to DRUG INEFFECTIVE. This represents approximately 16.5% of all 9,924 adverse event reports for this drug.
Patients taking TASIMELTEON who experience drug ineffective should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRUG INEFFECTIVE is a frequently reported adverse event for TASIMELTEON, accounting for a significant proportion of all reports.
In addition to drug ineffective, the following adverse reactions have been reported for TASIMELTEON:
The following drugs have also been linked to drug ineffective in FDA adverse event reports:
DRUG INEFFECTIVE has been reported as an adverse event in 1,635 FDA reports for TASIMELTEON. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRUG INEFFECTIVE accounts for approximately 16.5% of all adverse event reports for TASIMELTEON, making it one of the most commonly reported side effect.
If you experience drug ineffective while taking TASIMELTEON, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.